Sabal Trust’s Celgene Corp CELG Stock Holding History

Sabal Trust’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,600	Closed	-$311K	–	133
2015 Q4	$311K	Buy	+2,600	New	+$301K	0.04%	94

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Sabal Trust's CELG Position: Q1 2016 in Review

Sabal Trust sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 2,600 shares — an estimated $311K sold.

Sabal Trust first reported a position in CELG in Q4 2015 and held it in 1 quarter. The position peaked at $311K in Q4 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Sabal Trust reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
Sabal Trust sold 2,600 Celgene Corp shares in Q1 2016, an estimated $311K.
Sabal Trust first reported a position in Celgene Corp in Q4 2015 and held it in 1 quarter.
Sabal Trust's Celgene Corp position peaked at $311K in Q4 2015.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Sabal Trust's 13F filing for Q1 2016, filed 5 May 2016.